These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28291441)

  • 1. Surgical treatment of bilateral femoral stress fractures related with long-term alendronate therapy.
    Kanatlı U; Ataoğlu MB; Özer M; Topçu HN; Çetinkaya M
    Eklem Hastalik Cerrahisi; 2017 Apr; 28(1):55-8. PubMed ID: 28291441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy.
    Atik OS; Suluova F; Görmeli G; Yildirim A; Ali AKh
    Eklem Hastalik Cerrahisi; 2010 Apr; 21(1):56-9. PubMed ID: 20302562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate-associated femoral insufficiency fractures and femoral stress reactions.
    Wang K; Moaveni A; Dowrick A; Liew S
    J Orthop Surg (Hong Kong); 2011 Apr; 19(1):89-92. PubMed ID: 21519086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy.
    Gomberg SJ; Wustrack RL; Napoli N; Arnaud CD; Black DM
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1627-32. PubMed ID: 21430030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized cortical thickening of the femoral diaphysis captured on an X-ray before alendronate therapy in two cases of atypical femoral fracture.
    Iizuka Y; Takechi R; Iizuka H; Omodaka T; Takagishi K
    Skeletal Radiol; 2016 Oct; 45(10):1403-7. PubMed ID: 27402027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporotic fractures and vitamin D deficiency.
    Wong P; Anpalahan M
    Aust Fam Physician; 2006 Jul; 35(7):519-20, 522. PubMed ID: 16820826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
    Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH
    Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical femoral fracture following zoledronic acid treatment.
    Ataoğlu B; Kaptan AY; Eren TK; Yapar AE; Berkay AF
    Eklem Hastalik Cerrahisi; 2016; 27(1):54-7. PubMed ID: 26874637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy.
    Cermak K; Shumelinsky F; Alexiou J; Gebhart MJ
    Clin Orthop Relat Res; 2010 Jul; 468(7):1991-6. PubMed ID: 20020334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
    Ringe JD; Farahmand P; Schacht E; Rozehnal A
    Rheumatol Int; 2007 Mar; 27(5):425-34. PubMed ID: 17216477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical femoral fracture after long-term alendronate treatment: report of a case evidenced with magnetic resonance imaging.
    Kao CM; Huang PJ; Chen CH; Chen SJ; Cheng YM
    Kaohsiung J Med Sci; 2012 Oct; 28(10):555-8. PubMed ID: 23089322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.
    Capeci CM; Tejwani NC
    J Bone Joint Surg Am; 2009 Nov; 91(11):2556-61. PubMed ID: 19884427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
    Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
    Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.
    Lee JK
    Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Femoral canal obliteration secondary to prolonged alendronate use: a case report.
    Lim CT; Setiobudi T; Das De S
    J Orthop Surg (Hong Kong); 2012 Apr; 20(1):115-7. PubMed ID: 22535826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signs of Insufficiency Fractures Overlooked in a Patient Receiving Chronic Bisphosphonate Therapy.
    Shaikh W; Morris D; Morris S
    J Am Board Fam Med; 2016; 29(3):404-7. PubMed ID: 27170798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.
    Patel VC; Lazzarini AM
    Orthopedics; 2010 Oct; 33(10):775. PubMed ID: 20954650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy.
    Lin TL; Wang SJ; Fong YC; Hsu CJ; Hsu HC; Tsai CH
    BMC Res Notes; 2013 Jan; 6():11. PubMed ID: 23311861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate induced femur fracture complicated with secondary hyperparathyroidism.
    Jain SK; Roy SP; Nagi ON
    Mymensingh Med J; 2011 Jul; 20(3):501-6. PubMed ID: 21804520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.